Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$1.59 - $2.7 $318 - $540
200 Added 100.0%
400 $1,000
Q1 2022

May 16, 2022

BUY
$2.02 - $3.92 $404 - $784
200 New
200 $0
Q2 2021

Aug 16, 2021

SELL
$6.66 - $10.92 $14,751 - $24,187
-2,215 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$4.59 - $18.74 $9,221 - $37,648
2,009 Added 975.24%
2,215 $21,000
Q4 2020

Feb 16, 2021

SELL
$3.93 - $5.5 $357 - $500
-91 Reduced 30.64%
206 $1,000
Q3 2020

Nov 16, 2020

SELL
$4.01 - $5.56 $6,167 - $8,551
-1,538 Reduced 83.81%
297 $1,000
Q2 2020

Aug 14, 2020

BUY
$3.0 - $5.52 $5,505 - $10,129
1,835 New
1,835 $8,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $360M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.